Trupanion, Inc. (NASDAQ:TRUP) Shares Sold by Check Capital Management Inc. CA

Check Capital Management Inc. CA trimmed its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP) by 1.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 40,885 shares of the financial services provider’s stock after selling 575 shares during the period. Trupanion comprises 0.1% of Check Capital Management Inc. CA’s investment portfolio, making the stock its 20th largest position. Check Capital Management Inc. CA’s holdings in Trupanion were worth $1,971,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Quest Partners LLC acquired a new position in Trupanion during the third quarter valued at approximately $37,000. Wilmington Savings Fund Society FSB acquired a new position in Trupanion during the third quarter valued at approximately $54,000. KBC Group NV acquired a new position in Trupanion during the fourth quarter valued at approximately $75,000. R Squared Ltd acquired a new position in shares of Trupanion during the fourth quarter worth $79,000. Finally, GAMMA Investing LLC lifted its position in shares of Trupanion by 18.5% during the fourth quarter. GAMMA Investing LLC now owns 1,709 shares of the financial services provider’s stock worth $82,000 after purchasing an additional 267 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on TRUP. Stifel Nicolaus boosted their target price on shares of Trupanion from $42.00 to $44.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Northland Securities boosted their target price on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Finally, Piper Sandler raised shares of Trupanion from a “neutral” rating to an “overweight” rating and set a $57.00 target price on the stock in a research report on Thursday, January 23rd. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $45.33.

Insider Buying and Selling at Trupanion

In other Trupanion news, SVP Emily Dreyer sold 3,100 shares of the stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $54.85, for a total transaction of $170,035.00. Following the transaction, the senior vice president now directly owns 24,708 shares in the company, valued at $1,355,233.80. This represents a 11.15 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Fawwad Qureshi sold 9,867 shares of the stock in a transaction on Friday, November 29th. The shares were sold at an average price of $53.08, for a total transaction of $523,740.36. The disclosure for this sale can be found here. Insiders have sold 26,597 shares of company stock worth $1,416,742 in the last ninety days. 5.50% of the stock is owned by insiders.

Trupanion Stock Up 1.2 %

NASDAQ TRUP opened at $49.63 on Friday. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The company’s fifty day moving average price is $48.78 and its two-hundred day moving average price is $47.69.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.